According to our knowledge, the present study is the first that compares the diagnostic characteristics of all eotaxins and their receptor with the well-established tumor markers (CEA and CA 19-9) and the marker of inflammation (CRP) in CRC patients. The gene discussed is CRP; the disease is neoplasm.